Norton Healthcare-Norton Cancer Institute

Louisville, Kentucky 40207

0 studies enrolling now · 2 studies all time

What they study most

AML, Adult Recurrent, Carcinoma, Non-Small-Cell Lung, MDS

Studies at this site

• A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS) — Completed
• A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer — Stopped early